[HTML][HTML] Historical and current adenosine receptor agonists in preclinical and clinical development
KA Jacobson, DK Tosh, S Jain, ZG Gao - Frontiers in cellular …, 2019 - frontiersin.org
Adenosine receptors (ARs) function in the body's response to conditions of pathology and
stress associated with a functional imbalance, such as in the supply and demand of …
stress associated with a functional imbalance, such as in the supply and demand of …
Emerging adenosine receptor agonists
ZG Gao, KA Jacobson - Expert opinion on emerging drugs, 2007 - Taylor & Francis
Adenosine receptors (ARs) are a four-member subfamily of G protein-coupled receptors and
are major targets of caffeine and theophylline. There are four subtypes of ARs, designated …
are major targets of caffeine and theophylline. There are four subtypes of ARs, designated …
Medicinal chemistry and therapeutic potential of agonists, antagonists and allosteric modulators of A1 adenosine receptor: current status and perspectives
Adenosine is a purine nucleoside, responsible for the regulation of a wide range of
physiological and pathophysiological conditions by binding with four G-protein-coupled …
physiological and pathophysiological conditions by binding with four G-protein-coupled …
Adenosine receptor agonists: from basic medicinal chemistry to clinical development
L Yan, JC Burbiel, A Maaß… - Expert opinion on …, 2003 - Taylor & Francis
Adenosine is a physiological nucleoside which acts as an autocoid and activates G protein-
coupled membrane receptors, designated A1, A2A, A2B and A3. Adenosine plays an …
coupled membrane receptors, designated A1, A2A, A2B and A3. Adenosine plays an …
A2A adenosine receptor agonists and their potential therapeutic applications. An update
A Guerrero - Current medicinal chemistry, 2018 - ingentaconnect.com
Background: Adenosine is an endogenous purine nucleoside, which mediates a variety of
important biological processes and diseases, such as vasodilation, inflammation, cancer …
important biological processes and diseases, such as vasodilation, inflammation, cancer …
Adenosine receptors as drug targets—what are the challenges?
JF Chen, HK Eltzschig, BB Fredholm - Nature reviews Drug discovery, 2013 - nature.com
Adenosine signalling has long been a target for drug development, with adenosine itself or
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …
its derivatives being used clinically since the 1940s. In addition, methylxanthines such as …
Introduction to adenosine receptors as therapeutic targets
KA Jacobson - Adenosine receptors in health and disease, 2009 - Springer
Adenosine acts as a cytoprotective modulator in response to stress to an organ or tissue.
Although short-lived in the circulation, it can activate four subtypes of G protein-coupled …
Although short-lived in the circulation, it can activate four subtypes of G protein-coupled …
A1 adenosine receptor agonists and their potential therapeutic applications
E Elzein, J Zablocki - Expert opinion on investigational drugs, 2008 - Taylor & Francis
Background: The challenges in developing any A1 adenosine receptor (A1-AdoR) agonist
involve having the desired effect on target tissue while avoiding side effects due to activation …
involve having the desired effect on target tissue while avoiding side effects due to activation …
Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility
The purine nucleoside adenosine is consensually identified as a major local regulator of
tissue function especially when energy supply fails to meet cellular energy demand. Due to …
tissue function especially when energy supply fails to meet cellular energy demand. Due to …
[HTML][HTML] Pharmacology of adenosine receptors: Recent advancements
F Vincenzi, S Pasquini, C Contri, M Cappello, M Nigro… - Biomolecules, 2023 - mdpi.com
Adenosine receptors (ARs) are widely acknowledged pharmacological targets yet are still
underutilized in clinical practice. Their ubiquitous distribution in almost all cells and tissues …
underutilized in clinical practice. Their ubiquitous distribution in almost all cells and tissues …